AMRX vs. TEVA
AMRX (Amneal Pharmaceuticals, Inc.) and TEVA (Teva Pharmaceutical Industries Limited) are both stocks. Both operate in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Over the past 10 years, AMRX returned -5.48%/yr vs -3.60%/yr for TEVA. At a 0.37 correlation, their price movements are largely independent.
Performance
AMRX vs. TEVA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AMRX achieves a 32.22% return, which is significantly higher than TEVA's 6.41% return. Over the past 10 years, AMRX has underperformed TEVA with an annualized return of -5.48%, while TEVA has yielded a comparatively higher -3.60% annualized return.
AMRX
- 1D
- 3.41%
- 1M
- 34.14%
- YTD
- 32.22%
- 6M
- 29.75%
- 1Y
- 110.49%
- 3Y*
- 79.51%
- 5Y*
- 25.23%
- 10Y*
- -5.48%
TEVA
- 1D
- 3.14%
- 1M
- -2.52%
- YTD
- 6.41%
- 6M
- 5.29%
- 1Y
- 95.70%
- 3Y*
- 63.34%
- 5Y*
- 26.09%
- 10Y*
- -3.60%
AMRX vs. TEVA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
AMRX Amneal Pharmaceuticals, Inc. | 32.22% | 59.09% | 30.48% | 205.03% | -58.46% | 4.81% | -5.19% | -64.38% | -18.74% | 25.66% |
TEVA Teva Pharmaceutical Industries Limited | 6.41% | 41.61% | 111.11% | 14.47% | 13.86% | -16.99% | -1.53% | -36.45% | -18.63% | -46.18% |
Correlation
The correlation between AMRX and TEVA is 0.48, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.48 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.37 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.40 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.41 |
Correlation (All Time) Calculated using the full available price history since Jan 15, 2009 | 0.37 |
The correlation between AMRX and TEVA shifts across timeframes, from 0.37 (3 years) to 0.48 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
AMRX:
$5.48B
TEVA:
$39.15B
AMRX:
$0.38
TEVA:
$1.34
AMRX:
44.28
TEVA:
24.83
AMRX:
1.54
TEVA:
0.19
AMRX:
1.78
TEVA:
2.24
AMRX:
7.14
TEVA:
4.76
AMRX:
$3.05B
TEVA:
$17.35B
AMRX:
$1.18B
TEVA:
$9.03B
AMRX:
$626.02M
TEVA:
$3.05B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AMRX vs. TEVA — Risk / Return Rank
AMRX
TEVA
AMRX vs. TEVA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Amneal Pharmaceuticals, Inc. (AMRX) and Teva Pharmaceutical Industries Limited (TEVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AMRX | TEVA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.98 | ||
| Sortino ratioReturn per unit of downside risk | +0.45 | ||
| Omega ratioGain probability vs. loss probability | 1.52 | 1.46 | +0.05 |
| Calmar ratioReturn relative to maximum drawdown | 4.99 | 4.42 | +0.58 |
| Martin ratioReturn relative to average drawdown | 12.35 | 12.76 | -0.41 |
Loading charts...
Drawdowns
AMRX vs. TEVA - Drawdown Comparison
The maximum AMRX drawdown since its inception was -97.52%, which is greater than TEVA's maximum drawdown of -90.89%. Use the drawdown chart below to compare losses from any high point for AMRX and TEVA.
Loading charts...
Drawdown Indicators
| AMRX | TEVA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.52% | -90.89% | -6.63% |
Max Drawdown (1Y)Largest decline over 1 year | -22.25% | -21.79% | -0.46% |
Max Drawdown (3Y)Largest decline over 3 years | -26.80% | -43.70% | +16.90% |
Max Drawdown (5Y)Largest decline over 5 years | -78.29% | -43.70% | -34.59% |
Max Drawdown (10Y)Largest decline over 10 years | -95.98% | -88.41% | -7.57% |
Current DrawdownCurrent decline from peak | -67.53% | -50.91% | -16.62% |
Average DrawdownAverage peak-to-trough decline | -54.35% | -32.02% | -22.33% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.98% | 7.52% | +1.46% |
Volatility
AMRX vs. TEVA - Volatility Comparison
Amneal Pharmaceuticals, Inc. (AMRX) and Teva Pharmaceutical Industries Limited (TEVA) have volatilities of 11.67% and 11.74%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AMRX | TEVA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.67% | 11.74% | -0.07% |
Volatility (6M)Calculated over the trailing 6-month period | 24.41% | 24.47% | -0.06% |
Volatility (1Y)Calculated over the trailing 1-year period | 32.29% | 39.01% | -6.72% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 51.00% | 42.90% | +8.10% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 65.25% | 47.41% | +17.84% |
Dividends
AMRX vs. TEVA - Dividend Comparison
Neither AMRX nor TEVA has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AMRX Amneal Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
TEVA Teva Pharmaceutical Industries Limited | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 3.88% | 3.19% | 1.77% |
Financials
AMRX vs. TEVA - Financials Comparison
This section allows you to compare key financial metrics between Amneal Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AMRX vs. TEVA - Profitability Comparison
AMRX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Amneal Pharmaceuticals, Inc. reported a gross profit of 320.11M and revenue of 722.52M. Therefore, the gross margin over that period was 44.3%.
TEVA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Teva Pharmaceutical Industries Limited reported a gross profit of 1.97B and revenue of 3.98B. Therefore, the gross margin over that period was 49.5%.
AMRX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Amneal Pharmaceuticals, Inc. reported an operating income of 133.54M and revenue of 722.52M, resulting in an operating margin of 18.5%.
TEVA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Teva Pharmaceutical Industries Limited reported an operating income of 652.00M and revenue of 3.98B, resulting in an operating margin of 16.4%.
AMRX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Amneal Pharmaceuticals, Inc. reported a net income of 62.50M and revenue of 722.52M, resulting in a net margin of 8.7%.
TEVA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Teva Pharmaceutical Industries Limited reported a net income of 369.00M and revenue of 3.98B, resulting in a net margin of 9.3%.
Frequently Asked Questions
AMRX and TEVA have a correlation of 0.48, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TEVA has higher volatility (11.74%) compared to AMRX (11.67%). In terms of maximum drawdown, AMRX dropped -97.52% vs TEVA's -90.89%.
AMRX currently has the higher Sharpe Ratio (3.44 vs 2.47), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AMRX and TEVA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer